The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Caredx Inc (NASDAQ: CDNA) closed the day trading at $27.85 down -6.01% from the previous closing price of $29.63. In other words, the price has decreased by -$6.01 from its previous closing price. On the day, 0.59 million shares were traded. CDNA stock price reached its highest trading level at $30.0 during the session, while it also had its lowest trading level at $27.82.
Ratios:
For a better understanding of CDNA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 4.09. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.
On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’24 when Johnson Alexander L sold 39,466 shares for $33.17 per share. The transaction valued at 1,309,087 led to the insider holds 284,983 shares of the business.
Johnson Alexander L sold 21,557 shares of CDNA for $702,327 on Aug 21 ’24. The insider now owns 284,983 shares after completing the transaction at $32.58 per share. On Aug 20 ’24, another insider, Maag Peter, who serves as the Director of the company, sold 35,552 shares for $33.04 each. As a result, the insider received 1,174,493 and left with 330,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1468808960 and an Enterprise Value of 1365263488. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.94 while its Price-to-Book (P/B) ratio in mrq is 5.54. Its current Enterprise Value per Revenue stands at 4.596 whereas that against EBITDA is -21.896.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 7.51%, while the 200-Day Moving Average is calculated to be 86.73%.
Shares Statistics:
Over the past 3-months, CDNA traded about 932.53K shares per day on average, while over the past 10 days, CDNA traded about 690640 shares per day. A total of 51.50M shares are outstanding, with a floating share count of 49.35M. Insiders hold about 6.43% of the company’s shares, while institutions hold 97.01% stake in the company. Shares short for CDNA as of 1724976000 were 3307352 with a Short Ratio of 3.55, compared to 1722384000 on 3479756. Therefore, it implies a Short% of Shares Outstanding of 3307352 and a Short% of Float of 8.3100006.
